When the eye’s drainage system clogs, intraocular pressure (IOP) builds up and causes damage. The pressure can lead to glaucoma and vision loss. Researchers headed by a team at Duke University School ...

The intellectual property will enhance Liberate Bio’s LNP platform for selective programming of monocytes and macrophages.

In mice, the loss of long-lived resident macrophages in eye tissue disrupts pressure control, suggesting a potential new target for glaucoma treatment.

Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...

For decades, differences in pain between men and women have often been attributed to psychological, emotional or social ...

Hormone-regulated immune cells produce IL-10 to resolve pain more effectively in males, offering a potential new target for non-opioid chronic pain treatments.

Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, announces that it has secured exclusive and non-exclusive licenses to key ...

A specific subset of immune cells driven by testosterone resolves pain faster in men, explaining why women are more likely to experience chronic pain.

Why do diabetic wounds refuse to heal? A new scientific review highlights how disruptions in the timing and behavior of ...

Scientists have uncovered a powerful genetic switch that helps some of the body’s most important immune cells grow up properly and keep our organs healthy. The switch, called MafB, guides immature ...